Impact of <i>CYP2C9</i> and <i>VKORC1</i> Polymorphisms on Warfarin Sensitivity and Responsiveness in Jordanian Cardiovascular Patients during the Initiation Therapy
Warfarin is an oral anticoagulant frequently used in the treatment of different cardiovascular diseases. Genetic polymorphisms in the <i>CYP2C9</i> and <i>VKORC1</i> genes have produced variants with altered catalytic properties. A total of 212 cardiovascular patients were ge...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2018-11-01
|
| Series: | Genes |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4425/9/12/578 |